24-Hour control with a latanoprost-timolol fixed combination vs timolol alone

Area of Science:

• Ophthalmology
• Glaucoma Research
• Pharmacology

Background:

• Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
• Effective 24-hour intraocular pressure (IOP) control is crucial for managing POAG progression.
• Current treatments aim to reduce IOP, but achieving consistent control and minimizing fluctuation remains a challenge.

Purpose of the Study:

• To compare the efficacy of evening-dosed latanoprost-timolol maleate fixed combination versus timolol alone in controlling 24-hour IOP in POAG patients.
• To assess the impact of these treatments on IOP fluctuation over a 24-hour period.

Main Methods:

• A randomized, crossover study design was employed.
• Patients received either evening-dosed latanoprost-timolol fixed combination or twice-daily timolol alone for 8 weeks, followed by a switch to the alternative treatment.
• IOP measurements were taken at baseline and at the end of each treatment period.

Main Results:

• Both treatment regimens significantly reduced IOP from baseline.
• The latanoprost-timolol fixed combination demonstrated superior IOP reduction (2.9 mm Hg) compared to timolol alone across all time points and the 24-hour curve.
• The fixed combination also resulted in lower absolute IOP, reduced IOP fluctuation, and a narrower IOP range.

Conclusions:

• Evening-dosed latanoprost-timolol fixed combination provides enhanced 24-hour IOP control in POAG patients.
• This combination therapy may offer a more stable IOP profile, potentially leading to better disease management.
• While effective, adverse events like ocular stinging and hyperemia were more frequent with the fixed combination.